Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.1 USD | +5.00% | -4.11% | +11.11% |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | 3.57M | Capitalization | 164M |
---|---|---|---|---|---|
Net income 2024 * | -122M | Net income 2025 * | -125M | EV / Sales 2024 * | - |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 46 x |
P/E ratio 2024 * |
-1.09
x | P/E ratio 2025 * |
-1.07
x | Employees | 143 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 98.58% |
Latest transcript on Adicet Bio, Inc.
1 day | +10.25% | ||
1 week | -0.23% | ||
Current month | -7.02% | ||
1 month | -0.68% | ||
3 months | -12.95% | ||
6 months | +58.33% | ||
Current year | +15.61% |
Managers | Title | Age | Since |
---|---|---|---|
Aya Jakobovits
FOU | Founder | 71 | 14-10-31 |
Chen Schor
CEO | Chief Executive Officer | 51 | 16-06-30 |
Brian Harvey
DFI | Director of Finance/CFO | 63 | 20-08-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Steve Dubin
BRD | Director/Board Member | 70 | 20-09-14 |
Carl Gordon
CHM | Chairman | 59 | 15-08-14 |
Michael Kauffman
BRD | Director/Board Member | 60 | 21-11-16 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.03% | 0 M€ | 0.00% | - | |
0.02% | 0 M€ | 0.00% | - | |
0.00% | 9 M€ | +4.69% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-23 | 2.1 | +5.00% | 1 128 778 |
24-04-22 | 2 | +2.56% | 325,351 |
24-04-19 | 1.95 | -3.70% | 727,751 |
24-04-18 | 2.025 | -10.79% | 930,124 |
24-04-17 | 2.27 | +3.65% | 760,776 |
Delayed Quote Nasdaq, April 23, 2024 at 09:54 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+15.61% | 164M | |
+2.10% | 42.11B | |
+49.00% | 40.08B | |
+7.68% | 40B | |
-11.32% | 26.87B | |
+6.02% | 24.58B | |
-22.75% | 18.44B | |
+0.93% | 11.94B | |
+17.58% | 11.66B | |
+8.21% | 11.01B |
- Stock Market
- Equities
- ACET Stock